Latest Security News

360 Capital REIT (ASX – TOT) has reported a return to profitability in FY25, extending its debt facility and completing key leasing deals, while preparing for leasing challenges in FY26.

Highfield Resources faces a setback as China Minmetals and its subsidiary withdraw from a key strategic investment, triggering the maturity of convertible notes and raising questions about the future financing of the Muga potash project.

Bank of Queensland Limited announces a fully franked quarterly distribution of AUD 1.337 per Capital Note 3 security, payable in November 2025. The payment reflects a total annualised rate of 5.19%, based on the 3-month BBSW plus margin, adjusted for franking credits.

Star Minerals Limited has voluntarily suspended trading on the ASX pending an important announcement related to assay results and a price query. The suspension is expected to last until 20 August or until the announcement is released.

Power Minerals reports compelling high-grade niobium and rare earth element intersections from early-stage auger drilling at its Santa Anna Project in Brazil, extending the known mineralised footprint and reinforcing confidence in a significant resource.

Rhythm Biosciences has announced a $3.75 million placement to accelerate the commercial launch of its ColoSTAT® cancer detection test and expand its geneType™ product suite into key markets. The capital raise includes director participation and attaching options, pending shareholder approval.

Rhythm Biosciences is raising up to $3.75 million through a share placement to fund the launch of its ColoSTAT® colorectal cancer diagnostic and accelerate commercialization of its geneType™ portfolio.

360 Capital REIT has reported a significant turnaround with a $1.3 million statutory profit for FY25, alongside reduced distributions and a new long-term investment management agreement. The fund’s portfolio remains stable, supported by improved leasing and ESG upgrades.

Lendlease Group has announced a fully franked ordinary dividend of AUD 0.1696 per security for the first half of FY25, alongside a Dividend Reinvestment Plan with no discount.

Cleo Diagnostics has launched a health economic study in partnership with EntityRisk and Norstella to support the U.S. market entry of its Ovarian Cancer Pre-Surgical Test, aiming to refine reimbursement strategies and accelerate commercialisation.

ADX Energy has been awarded a new offshore gas exploration permit in the Sicily Channel, Italy, boasting significant prospective resources and strategic proximity to key infrastructure. The company plans further seismic work and drilling to unlock the permit’s potential.

Apiam Animal Health has received a non-binding indicative proposal from Adamantem Capital Management to acquire the company at $0.88 per share, sparking a potential shift in ownership for the veterinary services leader.